Heads up: some links below are affiliate links — assume any provider we list may compensate us, at no cost to you. It never buys a better score, but the providers we work with are listed first. See our affiliate disclosure.
vyrarx review
Publishes a floor and calls it a price — read live on 2026-08-21 the site says "From $179 /mo" for semaglutide and "From $329 /mo" for tirzepatide, and the word from is doing real work in both. No dose ladder, no maintenance rate and no ceiling appear anywhere on the public site, which means the number you would actually pay once you titrate up is the one piece of information the page does not give you. That matters more here than on a flat-price seller, because a floor tells you only where the billing starts. On the disclosure side it does better than several listings here: it names its operating entity, vyrarx, Inc., in its own Terms, and it screened clean against the full live FDA warning-letter index with four positive controls firing in the same pass. No state list is published, and nothing on the site addresses pregnancy, breastfeeding or postpartum timing.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
vyrarx at a glance
- Semaglutide
- $179/mo
- Tirzepatide
- $329/mo
- Coverage
- Not stated on the site
- Start
- Not published
How we scored vyrarx
Each factor is read off vyrarx's published pricing, disclosures and intake flow, and the six roll up into the 36/100 Rx-Readiness Score on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Limited or state-gated availability — confirm yours first.
The hardest start to fit around a workday — a scheduled visit, or no published answer either way.
Exit terms are the weak point: lock-in, notice periods, or a cancellation path that isn't published.
Not a two-molecule plan on the published facts — switching may mean starting again elsewhere.
The weakest showing on speed — a slow published timeline, or none at all.
Tiered or opaque — the true monthly is hard to pin down up front.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- vyrarx.com
"From $179" for semaglutide and "From $329" for tirzepatide — and "from" is doing real work, because no ceiling, dose ladder or maintenance rate is published anywhere. What you pay once the dose climbs is the one number the site does not give you.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutideInjectionRead live 2026-08-21: the site says "From $179 /mo". "From" is a floor, not a rate — no dose ladder or ceiling is published anywhere on the public site, so the number you actually pay at a maintenance dose is not disclosed. | $179 | InjectionRead live 2026-08-21: the site says "From $179 /mo". "From" is a floor, not a rate — no dose ladder or ceiling is published anywhere on the public site, so the number you actually pay at a maintenance dose is not disclosed. |
| Compounded tirzepatideInjectionRead live 2026-08-21: "From $329 /mo", same "From" framing and the same absent ceiling. | $329 | InjectionRead live 2026-08-21: "From $329 /mo", same "From" framing and the same absent ceiling. |
HSA/FSA generally applies to GLP-1 telehealth; confirm with your plan. These figures are vyrarx's public disclosures at last review and change often; confirm the current number on vyrarx's own site.
What we like
- Both starting figures are stated plainly on the homepage rather than hidden behind an intake
- Names its operating entity, vyrarx, Inc., in its own Terms — more than several sellers on this list
- Clean FDA warning-letter screen against the full live index
The caveats
- Both prices are prefixed "From" — a floor, not a rate, and no ceiling is published
- No dose ladder or maintenance price anywhere on the public site, so the cost once you titrate is unknown
- No state list published
- Nothing addresses pregnancy, breastfeeding or postpartum timing
vyrarx for working moms: our verdict
Publishes a floor and calls it a price — read live on 2026-08-21 the site says "From $179 /mo" for semaglutide and "From $329 /mo" for tirzepatide, and the word from is doing real work in both. No dose ladder, no maintenance rate and no ceiling appear anywhere on the public site, which means the number you would actually pay once you titrate up is the one piece of information the page does not give you. That matters more here than on a flat-price seller, because a floor tells you only where the billing starts. On the disclosure side it does better than several listings here: it names its operating entity, vyrarx, Inc., in its own Terms, and it screened clean against the full live FDA warning-letter index with four positive controls firing in the same pass. No state list is published, and nothing on the site addresses pregnancy, breastfeeding or postpartum timing. It runs about $179/month.
We weigh vyrarx the way working moms actually have to: not just the monthly line on your budget, but how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does — the parts a generic review does not measure.
What vyrarx will cost you
- Compounded semaglutide — Injection: $179/mo
- Compounded tirzepatide — Injection: $329/mo
That's roughly in line with the ~$179/month median across our roster.
The medications vyrarx prescribes
vyrarx prescribes semaglutide and tirzepatide — the two best-evidenced molecules in the class, and having both on one account matters because you can switch between them without re-enrolling or hunting down a new provider mid-plan. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where vyrarx fits — and where it doesn't — for working moms
Right for you if…
- the monthly line on your budget is a real barrier and you want a low, predictable number.
Not your best option if…
- you specifically want an FDA-approved brand pen and insurance navigation.
- you'd rather the most predictable place to start and pause — which is exactly what our #1 pick, CoreAge Rx, is designed around.
Trust, safety, and the fine print
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing working moms can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for working moms: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
vyrarx is a reasonable option — weigh it on how fast you can start without a scheduled video visit and a flat monthly price that doesn't climb as your dose does against the alternatives below. For most working moms, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for working moms
Best for: Someone comfortable starting a conversation without knowing what the maintenance dose will cost, who will get the ceiling in writing before entering a card.
Alternatives to vyrarx
Providers we have a referral relationship with, ordered by Rx-Readiness Score — highest first. A fee never moves a score, but it does decide who appears here, so this is not the full list: see the complete ranking.
- Visit CoreAge RxRx-Readiness95100CoreAge RxOur #1 pick
The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.
- Visit Pallas HealthRx-Readiness89100
Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.
- Visit Trimi HealthRx-Readiness88100
The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.
Keep comparing vyrarx
Head-to-head & alternatives
vyrarx, answered
- How much does vyrarx cost?
- Budget around $179 a month — that was vyrarx's lowest ongoing compounded rate at last review ($179/mo semaglutide, $329/mo tirzepatide). Verify the all-in figure on their site before you plan around it; these numbers change often.
- Can I start vyrarx without a scheduled video visit?
- vyrarx involves more clinician touchpoints (and, in some cases, a scheduled visit), so it isn't the fastest async start. If a no-video signup is your priority, our #1 pick is built for it.
- Does vyrarx offer both semaglutide and tirzepatide?
- Yes — vyrarx offers both molecules, so you can switch without re-enrolling. Tirzepatide's dual GIP/GLP-1 action posts the strongest published weight-loss numbers.
- Where does vyrarx rank for working moms?
- vyrarx earns 36/100 on our Rx-Readiness Score, ranking #299. Speed to first dose and flat pricing carry the most weight of the six factors behind it. CoreAge Rx leads — see how they compare.
Pricing, states and verification reflect vyrarx's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.